Major and minor salivary gland cancers: A multicenter retrospective study.
histopathology
incidence
major salivary gland
minor salivary gland
salivary gland cancers
Journal
Head & neck
ISSN: 1097-0347
Titre abrégé: Head Neck
Pays: United States
ID NLM: 8902541
Informations de publication
Date de publication:
07 2023
07 2023
Historique:
revised:
15
03
2023
received:
24
11
2022
accepted:
10
04
2023
medline:
8
6
2023
pubmed:
21
4
2023
entrez:
21
04
2023
Statut:
ppublish
Résumé
Most of the studies on salivary gland cancers are limited for various reasons such as being single-center, small number of patients, including only major or minor SGCs, or only including epidemiological data. A total of 37 medical oncology clinics from different regions of Turkey participated in this retrospective-multicenter study. The analyzed data included clinical and demographical features, primary treatment, metastasis localizations, and treatments and includes certain pathologic features. The study included data from a total of 443 SGCs. 56.7% was in major salivary glands and 43.3% was in minor salivary glands. Distant metastasis in the major SGCs was statistically significantly more common than in the minor SGCs, locoregional recurrence was statistically significantly more common in the minor SGCs than in the major SGCs (p = 0.003). Epidemiological information, metastasis and recurrence patterns, treatment modalities, and survival analysis of the patients over 20 years of follow-up are presented.
Sections du résumé
BACKGROUND
Most of the studies on salivary gland cancers are limited for various reasons such as being single-center, small number of patients, including only major or minor SGCs, or only including epidemiological data.
METHODS
A total of 37 medical oncology clinics from different regions of Turkey participated in this retrospective-multicenter study. The analyzed data included clinical and demographical features, primary treatment, metastasis localizations, and treatments and includes certain pathologic features.
RESULTS
The study included data from a total of 443 SGCs. 56.7% was in major salivary glands and 43.3% was in minor salivary glands. Distant metastasis in the major SGCs was statistically significantly more common than in the minor SGCs, locoregional recurrence was statistically significantly more common in the minor SGCs than in the major SGCs (p = 0.003).
CONCLUSIONS
Epidemiological information, metastasis and recurrence patterns, treatment modalities, and survival analysis of the patients over 20 years of follow-up are presented.
Types de publication
Multicenter Study
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1643-1653Informations de copyright
© 2023 The Authors. Head & Neck published by Wiley Periodicals LLC.
Références
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394-424.
Hay AJ, Migliacci J, Karassawa Zanoni D, McGill M, Patel S, Ganly I. Minor salivary gland tumors of the head and neck-Memorial Sloan Kettering experience: incidence and outcomes by site and histological type. Cancer. 2019;125(19):3354-3366.
Skálová A, Hyrcza MD, Leivo I. Update from the 5th edition of the World Health Organization classification of head and neck tumors: Salivary glands. Head Neck Pathol. 2022;16(1):40-53.
Fu JY, Wu CX, Shen SK, Zheng Y, Zhang CP, Zhang ZY. Salivary gland carcinoma in Shanghai (2003-2012): an epidemiological study of incidence, site and pathology. BMC Cancer. 2019;19(1):350.
Nachtsheim L, Mayer M, Meyer MF, et al. Incidence and clinical outcome of primary carcinomas of the major salivary glands: 10-year data from a population-based state cancer registry in Germany. J Cancer Res Clin Oncol. 2022; in press.
Sousa LG, Wang K, Torman D, et al. Treatment patterns and outcomes of palliative systemic therapy in patients with salivary duct carcinoma and adenocarcinoma, not otherwise specified. Cancer. 2022;128(3):509-518.
Carlson ER, Schlieve T. Salivary gland malignancies. Oral Maxillofac Surg Clin North Am. 2019;31(1):125-144.
Benchetrit L, Mehra S, Mahajan A, Rahmati RW, Judson BL, Edwards HA. Major salivary gland cancer with distant metastasis upon presentation: patterns, outcomes, and imaging implications. Otolaryngol Head Neck Surg. 2022;167(2):305-315.
Alsanie I, Rajab S, Cottom H, et al. Distribution and frequency of salivary gland tumours: an international multicenter study. Head Neck Pathol. 2022;16(4):1043-1054.
Mahomed Y, Meer S. Primary epithelial minor salivary gland tumors in South Africa: a 20-year review. Head Neck Pathol. 2020;14(3):715-723.
Coca-Pelaz A, Rodrigo JP, Bradley PJ, et al. Adenoid cystic carcinoma of the head and neck-An update. Oral Oncol. 2015;51(7):652-661.
Son E, Panwar A, Mosher CH, Lydiatt D. Cancers of the major salivary gland. J Oncol Pract. 2018;14(2):99-108.
Lee SY, Shin HA, Rho KJ, Chung HJ, Kim SH, Choi EC. Characteristics, management of the neck, and oncological outcomes of malignant minor salivary gland tumours in the oral and sinonasal regions. Br J Oral Maxillofac Surg. 2013;51(7):e142-e147.
Abdel Razek AAK, Mukherji SK. Imaging of minor salivary glands. Neuroimaging Clin N Am. 2018;28(2):295-302.
Copelli C, Bianchi B, Ferrari S, Ferri A, Sesenna E. Malignant tumors of intraoral minor salivary glands. Oral Oncol. 2008;44(7):658-663.
Pires FR, Pringle GA, de Almeida OP, Chen SY. Intra-oral minor salivary gland tumors: a clinicopathological study of 546 cases. Oral Oncol. 2007;43(5):463-470.
Nam SJ, Roh JL, Cho KJ, Choi SH, Nam SY, Kim SY. Risk factors and survival associated with distant metastasis in patients with carcinoma of the salivary gland. Ann Surg Oncol. 2016;23(13):4376-4383.
Ali S, Bryant R, Palmer FL, et al. Distant metastases in patients with carcinoma of the major salivary glands. Ann Surg Oncol. 2015;22(12):4014-4019.
Mimica X, McGill M, Hay A, et al. Distant metastasis of salivary gland cancer: incidence, management, and outcomes. Cancer. 2020;126(10):2153-2162.
Turchan WT, Korpics MC, Rooney M, Koshy M, Spiotto MT. Impact of anatomic site of distant metastasis on survival in salivary gland cancers. Head Neck. 2021;43(9):2589-2601.
Young A, Okuyemi OT. Malignant Salivary Gland Tumors. StatPearls; 2022.
Lombardi D, McGurk M, Vander Poorten V, et al. Surgical treatment of salivary malignant tumors. Oral Oncol. 2017;65:102-113.
Rosenberg L, Weissler M, Hayes DN, et al. Concurrent chemoradiotherapy for locoregionally advanced salivary gland malignancies. Head Neck. 2012;34(6):872-876.
Gebhardt BJ, Ohr JP, Ferris RL, et al. Concurrent chemoradiotherapy in the adjuvant treatment of high-risk primary salivary gland malignancies. Am J Clin Oncol. 2018;41(9):888-893.
Park GC, Roh JL, Cho KJ, et al. Incidence and risk factors of late recurrence in patients with salivary gland cancer. Clin Otolaryngol. 2017;42(2):416-424.
Tchekmedyian V. Salivary gland cancers. Hematol Oncol Clin North Am. 2021;35(5):973-990.
Liu Y, Mi Y, Zhang L, Gong Q, Jiang T. Prognostic analysis and establishment of a nomogram in patients with myoepithelial carcinoma of the salivary gland: a population-based study. Laryngosc Investig Otolaryngol. 2022;7(1):125-134.
Boon E, Bel M, van Boxtel W, et al. A clinicopathological study and prognostic factor analysis of 177 salivary duct carcinoma patients from The Netherlands. Int J Cancer. 2018;143(4):758-766.
Amit M, Binenbaum Y, Sharma K, et al. Analysis of failure in patients with adenoid cystic carcinoma of the head and neck.; An International collaborative study. Head Neck. 2014;36(7):998-1004.
Ali S, Palmer FL, Yu C, et al. A predictive nomogram for recurrence of carcinoma of the major salivary glands. JAMA Otolaryngol Head Neck Surg. 2013;139(7):698-705.
Terhaard CH, Lubsen H, Van der Tweel I, et al. Salivary gland carcinoma: independent prognostic factors for locoregional control, distant metastases, and overall survival: results of the Dutch head and neck oncology cooperative group. Head Neck. 2004;26(8):681-692; discussion 692-683, 693.
Jia MQ, Gao M, Ye P, et al. Survival outcome of salivary gland carcinoma: a 50-year retrospective study with long-term follow-up. J Oral Maxillofac Surg. 2022;80:2003-2014.
Hosni A, Huang SH, Goldstein D, et al. Outcomes and prognostic factors for major salivary gland carcinoma following postoperative radiotherapy. Oral Oncol. 2016;54:75-80.
Szewczyk M, Golusiński P, Pazdrowski J, et al. Patterns of treatment failure in salivary gland cancers. Rep Pract Oncol Radiother. 2018;23(4):260-265.
Kim HR, Lee SJ, Park S, et al. A single-arm, prospective, phase II study of cisplatin plus weekly docetaxel as first-line therapy in patients with metastatic or recurrent Salivary gland cancer. Cancer Res Treat. 2022;54(3):719-727.
Witte HM, Gebauer N, Lappöhn D, et al. Prognostic impact of PD-L1 expression in malignant salivary gland tumors as assessed by established scoring criteria: tumor proportion score (TPS), combined positivity score (CPS), and immune cell (IC) infiltrate. Cancers (Basel). 2020;12(4):873.
Guazzo E, Cooper C, Wilkinson L, et al. Therapeutic implications of immune-profiling and EGFR expression in salivary gland carcinoma. Head Neck. 2021;43(3):768-777.
Steiniche T, Ladekarl M, Georgsen JB, et al. Association of programmed death ligand 1 expression with prognosis among patients with ten uncommon advanced cancers. Future Sci OA. 2020;6(8):FSO616.
Weaver AN, Lakritz S, Mandair D, et al. A molecular guide to systemic therapy in salivary gland carcinoma. Head Neck. 2023;45:1315-1326.